Race, substance use, and evaluation for heart transplantation: Insights from a large urban medical center

J Heart Lung Transplant. 2024 Sep;43(9):1521-1524. doi: 10.1016/j.healun.2024.05.011. Epub 2024 May 17.

Abstract

It is unknown whether racial disparities in access to heart transplantation (HT) are amplified when coupled with substance use. We examined patients evaluated for HT over 8 years at an urban transplant center. We evaluated substance use and race/ethnicity as independent and interactive predictors of HT and left ventricular assist device (LVAD) implantation. Of 1,148 patients evaluated for HT, substance use was cited as an ineligibility factor in 151 (13%) patients, 16 (11%) of whom ultimately received HT. Significantly more non-Hispanic Black (NHB) patients were deemed ineligible due to substance use (n = 59, 19%) compared to other races/ethnicities (non-Hispanic white: n = 68, 12%; other race/ethnicity: n = 24, p = 0.002). No racial differences were observed in the likelihood of HT among patients initially excluded for substances, but more NHB patients ultimately received LVAD than the other racial groups. This study encourages greater awareness of the role of substance use and race in the HT evaluation.

Keywords: disparities; health equity; heart transplantation; left ventricular assist device; substance use.

MeSH terms

  • Adult
  • Aged
  • Black or African American
  • Female
  • Healthcare Disparities / ethnology
  • Healthcare Disparities / statistics & numerical data
  • Heart Failure / ethnology
  • Heart Failure / surgery
  • Heart Transplantation* / statistics & numerical data
  • Heart-Assist Devices*
  • Humans
  • Male
  • Middle Aged
  • Racial Groups
  • Retrospective Studies
  • Substance-Related Disorders* / epidemiology
  • Substance-Related Disorders* / ethnology
  • White